Role of tissue transglutaminase and effect of cantharidinate in human colorectal cancer

Molecular Medicine Reports

Volumn 8, Issue 6, 2013, Pages 1812-1816

  Yang, Lan Lan ^a   Liang, Chong Yang ^a   Lu, Tian Cheng ^b   Zhi, Chen Yang ^c   Liu, Bin ^d   Zhou, Jian Hua ^b   Liu, Xu Ming ^c   Gao, Hai Cheng ^a   Huang, Wei ^e  

^a JILIN UNIVERSITY   (China)

^b JILIN AGRICULTURAL UNIVERSITY   (China)

^c CHANGCHUN UNIVERSITY   (China)

^d THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^e THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Cantharidinate; Colorectal cancer; Molecular target; Tissue transglutaminase

Indexed keywords

ANTINEOPLASTIC AGENT; CANTHARIDINATE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TISSUE TRANSGLUTAMINASE; UNCLASSIFIED DRUG; CANTHARIDIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; VERY ELDERLY; YOUNG ADULT; COHORT ANALYSIS; COLORECTAL NEOPLASMS; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; STAINING; TREATMENT OUTCOME; TUMOR CELL LINE;

ADULT; AGED; AGED, 80 AND OVER; CANTHARIDIN; CELL LINE, TUMOR; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RNA, MESSENGER; STAINING AND LABELING; TRANSGLUTAMINASES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84893760137     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1706     Document Type: Article

References (24)

1. Deng X, Cao Y, Liu Y, Li F, Sambandam K, Rajaraman S, Perkins AS, Fields AP, Hellmich MR, Townsend CM Jr, et al: Overexpression of Evi-1 oncoprotein represses TGF-β signaling in colorectal cancer. Mol Carcinog 52: 255-264, 2013.
2. Potter JD: Colorectal cancer: molecules and populations. J Natl Cancer Inst 91: 916-932, 1999.
3. Deschoolmeester V, Baay M, Specenier P, Lardon F and Vermorken JB: A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy. Oncologist 15: 699-731, 2010.
4. Kotzev I, Mirchev M, Manevska B, Ivanova I and Kaneva M: Risk and protective factors for development of colorectal polyps and cancer (Bulgarian experience). Hepatogastroenterology 55: 381-387, 2008.
5. Domínguez-Ayala M, Díez-Vallejo J and Comas-Fuentes A: Missed opportunities in early diagnosis of symptomatic colorectal cancer. Rev Esp Enferm Dig 104: 343-349, 2012.
6. Jass JR: Colorectal cancer: a multipathway disease. Crit Rev Oncog 12: 273-287, 2006.
7. Fearon ER: Molecular genetics of colorectal cancer. Annu Rev Pathol 6: 479-507, 2011.
8. Posner MR: Paradigm shift in the treatment of head and neck cancer: the role of neoadjuvant chemotherapy. Oncologist 10 (Suppl 3): 11-19, 2005.
9. Simoglou C, Gymnopoulou E, Simoglou L, Gymnopoulou M, Nikolaou K and Gymnopoulos D: Surgery for colorectal cancer in the small town of Komotini. J Multidiscip Healthc 5: 273-276, 2012.
10. Hu Y, Zhang H, Xiong X, Cao Y, Han Y and Xi Z: Inhibitory effect of tissue transglutaminase (tTG) antisense oligodeoxynucleotides on tTG expression in cultured bovine trabecular meshwork cells. J Huazhong Univ Sci Technolog Med Sci 25: 729-731, 2005.
11. van Hazel GA, Pavlakis N, Goldstein D, Olver IN, Tapner MJ, Price D, Bower GD, Briggs GM, Rossleigh MA, Taylor DJ and George J: Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. J Clin Oncol 27: 4089-4095, 2009.
12. Gerber DE: Targeted therapies: a new generation of cancer treatments. Am Fam Physician 77: 311-319, 2008.
13. Dehmer GJ, Douglas JS Jr, Abizaid A, et al: SCAI/ACCF/HRS/ESC/SOLACI/ APSIC statement on the use of live case demonstrations at cardiology meetings: assessments of the past and standards for the future. Heart Rhythm 7: 1522-1535, 2010.
14. Liu HG and Huang HX: Overview pharmacokinetic about traditional Chinese medicine in recent 10 years. Zhongguo Zhong Yao Za Zhi 32: 2346-2348, 2007 (In Chinese).
15. Honkanen RE: Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A. FEBS Lett 330: 283-286, 1993.
16. Deng LP, Dong J, Cai H and Wang W: Cantharidin as an antitumor agent: a retrospective review. Curr Med Chem 20: 159-166, 2013.
17. Huang YP, Ni CH, Lu CC, et al: Suppressions of migration and invasion by cantharidin in TSGH-8301 human bladder carcinoma cells through the inhibitions of matrix metalloproteinase-2/?9 signaling. Evid Based Complement Alternat Med 2013: 190281, 2013.
18. Zhan YP, Huang XE, Cao J, et al: Clinical study on safety and efficacy of Qinin® (cantharidin sodium) injection combined with chemotherapy in treating patients with gastric cancer. Asian Pac J Cancer Prev 13: 4773-4776, 2012.
19. Kim YM, Ku MJ, Son YJ, Yun JM, Kim SH and Lee SY: Anti-metastatic effect of cantharidin in A549 human lung cancer cells. Arch Pharm Res 36: 479-484, 2013.
20. Yeh CH, Yang YY, Huang YF, Chow KC and Chen MF: Induction of apoptosis in human Hep3B hepatoma cells by norcantharidin through a p53 independent pathway via TRAIL/DR5 signal transduction. Chin J Integr Med 18: 676-682, 2012.
21. Agnihotri N, Kumar S and Mehta K: Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer. Breast Cancer Res 15: 202, 2013.
22. Yakubov B, Chelladurai B, Schmitt J, Emerson R, Turchi JJ and Matei D: Extracellular tissue transglutaminase activates noncanonical NF-?B signaling and promotes metastasis in ovarian cancer. Neoplasia 15: 609-619, 2013.
23. Caffarel MM, Chattopadhyay A, Araujo AM, Bauer J, Scarpini CG and Coleman N: Tissue transglutaminase mediates the pro-malignant effects of oncostatin M receptor over-expression in cervical squamous cell carcinoma. J Pathol 231: 168-179, 2013.
24. Wang Z, Perez M, Caja S, Melino G, Johnson TS, Lindfors K and Griffin M: A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis. Cell Death Dis 4: e808, 2013.